<code id='0084BE3B66'></code><style id='0084BE3B66'></style>
      • <acronym id='0084BE3B66'></acronym>
      <center id='0084BE3B66'><center id='0084BE3B66'><tfoot id='0084BE3B66'></tfoot></center><abbr id='0084BE3B66'><dir id='0084BE3B66'><tfoot id='0084BE3B66'></tfoot><noframes id='0084BE3B66'>
      • <optgroup id='0084BE3B66'><strike id='0084BE3B66'><sup id='0084BE3B66'></sup></strike><code id='0084BE3B66'></code></optgroup>
        5. <b id='0084BE3B66'><label id='0084BE3B66'><select id='0084BE3B66'><dt id='0084BE3B66'><span id='0084BE3B66'></span></dt></select></label></b><u id='0084BE3B66'></u>
          <i id='0084BE3B66'><strike id='0084BE3B66'><tt id='0084BE3B66'><pre id='0084BE3B66'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-06 08:10:59 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：Wikipedia   
                                        
                                      
                                      Page View：11335
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          It's time to retire 'poor historian' from clinicians' vocabularies
                                
                            
          Next article：  
                                      
                                          Walensky prepares to leave CDC — and Congress — behind
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles